<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04325113</url>
  </required_header>
  <id_info>
    <org_study_id>Tonsilstopic</org_study_id>
    <nct_id>NCT04325113</nct_id>
  </id_info>
  <brief_title>Post Tonsillectomy Analgesia Comparison After Surgery Site Spray of Local Anesthesics</brief_title>
  <official_title>Post Tonsillectomy Analgesia Comparison After Surgery Site Spray of NaCl 0,9%, Xylocaine 2% or Levobupivacaine 0,5%</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Liege</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Liege</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Check analgesia after tonsillectomy in adults
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We hypothesize that a vaporization of local anesthetics in the tonsil lodge would reduce
      postoperative pain.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 7, 2019</start_date>
  <completion_date type="Actual">January 15, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient's satisfaction and pain score</measure>
    <time_frame>until 10 days after the tonsillectomy.</time_frame>
    <description>patient satisfaction and pain score using a visual anagogic scale from 0 (no pain) to 10 (intolerable pain)</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>NaCl 0,9%</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>patients receive 5ml of NaCl 0,9% at the level of the tonsils lodge</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Xylocaine 2%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients receive 5ml of Xylocaïne 2% at the level of the tonsils lodge</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Levobupivacaine 0,5%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients receive 5ml of Levobupivacaine 0,5% at the level of the tonsils lodge</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>levobupivacaine</intervention_name>
    <description>Patient satisfaction and pain score using a visual anagogic scale (VAS)</description>
    <arm_group_label>Levobupivacaine 0,5%</arm_group_label>
    <arm_group_label>NaCl 0,9%</arm_group_label>
    <arm_group_label>Xylocaine 2%</arm_group_label>
    <other_name>xylocaine</other_name>
    <other_name>Nacl</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Tonsillectomy

        Exclusion Criteria:

          -  Gastric or duodenal ulcer

          -  Diabetes

          -  Kidney failure

          -  Chronic pain and fibromyalgia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Javillier</name>
      <address>
        <city>Liège</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 24, 2020</study_first_submitted>
  <study_first_submitted_qc>March 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2020</study_first_posted>
  <last_update_submitted>March 26, 2020</last_update_submitted>
  <last_update_submitted_qc>March 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Liege</investigator_affiliation>
    <investigator_full_name>Benjamin Javillier</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Agnosia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levobupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

